Westamerica Bancorporation
8 nominees · 3 ballot items.
Elect eight directors; approve a non-binding advisory 'say-on-pay' vote on named executive officer compensation; ratify Crowe LLP as independent auditor; and transact any other properly presented business.
Follow how the vote landed and what changed on Westamerica Bancorporation’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect eight directors to serve until the 2027 Annual Meeting of Shareholders.
- 2
Approve a non-binding advisory vote on the compensation of our named executive officers
ManagementBoard: FORNon-binding advisory 'say-on-pay' vote to approve the compensation of the named executive officers as disclosed in the proxy statement (CD&A, compensation tables and related disclosure).
More detail
This management proposal asks shareholders to cast a non-binding advisory vote to approve the compensation paid to the named executive officers as disclosed in the proxy statement. Management is seeking shareholder approval to reaffirm its compensation program that it describes as pay‑for‑performance, comprised of limited base salaries and incentive compensation in the form of annual cash bonuses and long‑term equity awards (restricted performance shares (RPS) and nonqualified stock options (NQSOs)). The proxy explains that RPS vesting is contingent on multi-year performance metrics (EPS, ROA, ROE differential, non‑performing assets and efficiency ratio), awards generally vest over three years, and compensation decisions are overseen by an independent Compensation Committee. The filing highlights program safeguards including a clawback policy, limits on option repricing, and diversified performance metrics intended to avoid excessive risk‑taking. Management points to historical shareholder support (99% support last year) and explains the vote is advisory and non‑binding, but that the Compensation Committee will consider the outcome when setting future pay. The Board recommends FOR because it believes the mix of incentives aligns executives with long‑term shareholder interests and prudent risk management. From a governance perspective, investors should weigh the program’s apparent alignment features, the presence of independent committee oversight, and whether disclosure demonstrates that performance targets and outcomes are appropriately calibrated. The advisory nature means even if approved, shareholders have limited direct remediation avenues other than engaging with the Board and voting on directors and future advisory proposals.
- 3
Ratify selection of independent auditor
ManagementBoard: FORRatify the Audit Committee’s selection of Crowe LLP as Westamerica Bancorporation’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Nominees on the ballot8
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.8% | 2,540,747 | $132M |
| 2 | AMERICAN CENTURY COMPANIES INC | 8.1% | 1,906,870 | $99M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.5% | 1,759,550 | $92M |
| 4 | STATE STREET CORP | 5.1% | 1,203,283 | $63M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.7% | 1,095,078 | $57M |
| 6 | DIMENSIONAL FUND ADVISORS LP | 3.7% | 880,106 | $46M |
| 7 | BlackRock, Inc. | 2.9% | 679,869 | $35M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 527,071 | $27M |
| 9 | AQR CAPITAL MANAGEMENT LLC | 1.7% | 392,451 | $20M |
| 10 | TWO SIGMA INVESTMENTS, LP | 1.5% | 353,032 | $18M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Westamerica Bancorporation’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Westamerica Bancorporation 2026 annual meeting?
- Westamerica Bancorporation (WABC) holds its 2026 annual shareholder meeting on Thursday, April 23, 2026.
- What is the record date for the Westamerica Bancorporation 2026 meeting?
- The record date for the Westamerica Bancorporation 2026 meeting is Wednesday, March 4, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Westamerica Bancorporation's 2026 meeting?
- The board is presenting 8 director nominees at the Westamerica Bancorporation 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Westamerica Bancorporation 2026 meeting?
- Shareholders will vote on 3 proposals at the Westamerica Bancorporation 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.